Charles River Laboratories International, Inc. (CRL)
NYSE · Healthcare
Charles River Laboratories International, Inc. Balance Sheet 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 7.14B | 7.53B | 8.20B | 7.60B | 7.02B | 5.49B |
| Cash & Equivalents | 213.8M | 194.6M | 276.8M | 233.9M | 241.2M | 228.4M |
| Liabilities | ||||||
| Total Liabilities | 3.92B | 4.02B | 4.54B | 4.58B | 4.43B | 3.35B |
| Long-Term Debt | 2.57B | 2.72B | 3.07B | 3.10B | 2.92B | 2.09B |
| Equity | ||||||
| Shareholders' Equity | 3.21B | 3.51B | 3.66B | 3.02B | 2.59B | 2.14B |
Charles River Laboratories International, Inc. Balance Sheet — FAQ
Charles River Laboratories International, Inc. (CRL) balance sheet over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRL's balance sheet history?
The chart and table above show Charles River Laboratories International, Inc.'s balance sheet by year and by quarter, including the growth rate.